Insights
Around The World in HTAs: Türkiye – The bumpy road toward transformation
31 January 2024
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Prof Hasan Huseyin Yildirim, Dilek Sernur Eminoğulları, Dr Tuba Saygın Avşar, and Patricia Cubi-Molla take us to Türkiye.
Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA
17 January 2024
In this insight, commissioned and funded by Chiesi S.p.A, we reflect on the discussions that took place at ISPOR Europe 2023 and how environmental impact is factored into HTA.
Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics
16 January 2024
Insight 3 of this series provides an exploration of revenue guarantee/subscription models and how they could be implemented in the EU.
Could Plant-based Diets Transform Health Care Spending?
8 January 2024
In a bid to reduce health care budgets, policymakers and healthcare professionals are increasingly looking to prevention strategies.
Breaking the European Deadlock: Part 2 – Transferable Exclusivity Vouchers – Effective Pull Incentive or a Policy Distraction?
4 January 2024
This is part 2 of the insight series which explores how progress towards an effective pull incentive for antibiotics can be made in Europe.
Reimagining Prevention for a Healthier, More Prosperous Society: Webinar Insights
7 December 2023
OHE held a webinar expanding on the findings and recommendations outlined in the recent whitepaper report. The event brought together experts from government, industry, and academia to share insights, focusing on strategies aimed at spearheading a transformative era of prevention.
The Inflation Reduction Act: Price negotiation underway for the first 10 drugs
29 November 2023
The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were announced at the end of August. We discuss what they are, what they show us, and the potential ripple effects.
OHE’s AMR consultation response
21 November 2023
This blog summarises our perspective on the recent proposals set out by NHS England to assess the value of new antibiotics via a new scoring system linked to a volume-delinked revenue guarantee payment. Key arguments outlined here were submitted to NHS England as part of OHE’s response to the consultation on proposals.
An eye on sustainability at the Economist’s Future of Health Europe
30 October 2023
Learn more about how the topic of sustainability was tackled by a broad range of speakers and the key themes which emerged.